ReviewTherapeutics and clinical risk management2022

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives.

Galina Tsykunova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.